747 related articles for article (PubMed ID: 12435633)
41. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
42. Senescence of human fibroblasts induced by oncogenic Raf.
Zhu J; Woods D; McMahon M; Bishop JM
Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
[TBL] [Abstract][Full Text] [Related]
43. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
44. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
45. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
46. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y; Xiong Y
Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
[TBL] [Abstract][Full Text] [Related]
47. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
[TBL] [Abstract][Full Text] [Related]
48. Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation.
Fanton CP; McMahon M; Pieper RO
J Biol Chem; 2001 Jun; 276(22):18871-7. PubMed ID: 11278920
[TBL] [Abstract][Full Text] [Related]
49. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
50. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
51. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
52. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
[TBL] [Abstract][Full Text] [Related]
53. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.
Kodama R; Kato M; Furuta S; Ueno S; Zhang Y; Matsuno K; Yabe-Nishimura C; Tanaka E; Kamata T
Genes Cells; 2013 Jan; 18(1):32-41. PubMed ID: 23216904
[TBL] [Abstract][Full Text] [Related]
54. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
55. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
[TBL] [Abstract][Full Text] [Related]
56. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
57. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
58. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.
Xiong Y; Kuppuswamy D; Li Y; Livanos EM; Hixon M; White A; Beach D; Tlsty TD
J Virol; 1996 Feb; 70(2):999-1008. PubMed ID: 8551641
[TBL] [Abstract][Full Text] [Related]
59. The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis.
Paramio JM; Segrelles C; Ruiz S; Martin-Caballero J; Page A; Martinez J; Serrano M; Jorcano JL
J Biol Chem; 2001 Nov; 276(47):44203-11. PubMed ID: 11551927
[TBL] [Abstract][Full Text] [Related]
60. Long-term growth arrest of PUVA-treated fibroblasts in G2/M in the absence of p16(INK4a) p21(CIP1) or p53.
Ma W; Hommel C; Brenneisen P; Peters T; Smit N; Sedivy J; Scharffetter-Kochanek K; Wlaschek M
Exp Dermatol; 2003 Oct; 12(5):629-37. PubMed ID: 14705804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
